PH12015501310B1 - NUTRIENT ENRICHED MEDIA FOR hUTC GROWTH - Google Patents

Info

Publication number

PH12015501310B1

PH12015501310B1 PH12015501310A PH12015501310A PH12015501310B1 PH 12015501310 B1 PH12015501310 B1 PH 12015501310B1 PH 12015501310 A PH12015501310 A PH 12015501310A PH 12015501310 A PH12015501310 A PH 12015501310A PH 12015501310 B1 PH12015501310 B1 PH 12015501310B1

Authority

PH

Philippines

Prior art keywords

cells

cell

microcarriers

medium

culture

Prior art date

2012-12-14

Links

• Espacenet
• Global Dossier
• Discuss

• 235000015097 nutrients Nutrition 0.000 title claims abstract description 95
• 230000012010 growth Effects 0.000 title description 55
• 239000001963 growth medium Substances 0.000 claims abstract description 170
• 238000000034 method Methods 0.000 claims abstract description 140
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims abstract description 60
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract description 57
• 210000002966 serum Anatomy 0.000 claims abstract description 50
• 229940088594 vitamin Drugs 0.000 claims abstract description 36
• 229930003231 vitamin Natural products 0.000 claims abstract description 36
• 235000013343 vitamin Nutrition 0.000 claims abstract description 36
• 239000011782 vitamin Substances 0.000 claims abstract description 36
• 150000001413 amino acids Chemical class 0.000 claims abstract description 31
• 102000004877 Insulin Human genes 0.000 claims abstract description 28
• 108090001061 Insulin Proteins 0.000 claims abstract description 28
• 102000004338 Transferrin Human genes 0.000 claims abstract description 28
• 108090000901 Transferrin Proteins 0.000 claims abstract description 28
• 229940125396 insulin Drugs 0.000 claims abstract description 28
• 239000012581 transferrin Substances 0.000 claims abstract description 28
• 239000002777 nucleoside Substances 0.000 claims abstract description 26
• HVAKSLUOHARFLM-UHFFFAOYSA-N selenium;sodium Chemical compound [Se][Na] HVAKSLUOHARFLM-UHFFFAOYSA-N 0.000 claims abstract description 8
• 210000003954 umbilical cord Anatomy 0.000 claims description 72
• 241000282414 Homo sapiens Species 0.000 claims description 55
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims description 46
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 claims description 46
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 46
• 235000019136 lipoic acid Nutrition 0.000 claims description 44
• 229960002663 thioctic acid Drugs 0.000 claims description 44
• AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 41
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims description 40
• 238000012258 culturing Methods 0.000 claims description 38
• 238000010899 nucleation Methods 0.000 claims description 38
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 24
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 24
• UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 claims description 23
• 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 23
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims description 23
• UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 claims description 23
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims description 23
• 229960005305 adenosine Drugs 0.000 claims description 23
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 claims description 23
• UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims description 23
• 229940029575 guanosine Drugs 0.000 claims description 23
• 125000003835 nucleoside group Chemical group 0.000 claims description 23
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 claims description 23
• 229940045145 uridine Drugs 0.000 claims description 23
• AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 22
• 210000004369 blood Anatomy 0.000 claims description 21
• 239000008280 blood Substances 0.000 claims description 21
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 claims description 20
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 claims description 20
• 229940104230 thymidine Drugs 0.000 claims description 20
• 102100022749 Aminopeptidase N Human genes 0.000 claims description 18
• 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 claims description 18
• 150000003839 salts Chemical class 0.000 claims description 18
• 101001008874 Homo sapiens Mast/stem cell growth factor receptor Kit Proteins 0.000 claims description 15
• 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 claims description 15
• 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 13
• 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 13
• 102000006354 HLA-DR Antigens Human genes 0.000 claims description 12
• 108010058597 HLA-DR Antigens Proteins 0.000 claims description 12
• 229940031098 ethanolamine Drugs 0.000 claims description 4
• AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims description 3
• 230000001419 dependent effect Effects 0.000 abstract description 39
• 210000004027 cell Anatomy 0.000 description 750
• 239000000243 solution Substances 0.000 description 136
• 239000002609 medium Substances 0.000 description 130
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 123
• 210000001519 tissue Anatomy 0.000 description 114
• 239000012091 fetal bovine serum Substances 0.000 description 103
• -1 sodium phosphate, dibasic heptahydrate Chemical class 0.000 description 55
• 239000002054 inoculum Substances 0.000 description 48
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 42
• 239000002953 phosphate buffered saline Substances 0.000 description 42
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 41
• 108090000623 proteins and genes Proteins 0.000 description 40
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 36
• 230000005484 gravity Effects 0.000 description 36
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 35
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 35
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 35
• RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 35
• 229960001031 glucose Drugs 0.000 description 35
• OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 34
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 33
• LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 33
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 31
• 239000000203 mixture Substances 0.000 description 31
• 239000006228 supernatant Substances 0.000 description 31
• 108060005980 Collagenase Proteins 0.000 description 30
• 102000029816 Collagenase Human genes 0.000 description 30
• 102000004190 Enzymes Human genes 0.000 description 30
• 108090000790 Enzymes Proteins 0.000 description 30
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 30
• RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 30
• 229940088598 enzyme Drugs 0.000 description 30
• 235000002639 sodium chloride Nutrition 0.000 description 30
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 29
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 29
• 229960002424 collagenase Drugs 0.000 description 29
• 238000004519 manufacturing process Methods 0.000 description 29
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 28
• KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 28
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 27
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 27
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 27
• 229940024606 amino acid Drugs 0.000 description 27
• 235000001014 amino acid Nutrition 0.000 description 27
• 239000008103 glucose Substances 0.000 description 27
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 26
• 229910002091 carbon monoxide Inorganic materials 0.000 description 26
• 230000014509 gene expression Effects 0.000 description 26
• 210000000130 stem cell Anatomy 0.000 description 26
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 25
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 25
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 25
• 108010007093 dispase Proteins 0.000 description 24
• 229930182816 L-glutamine Natural products 0.000 description 23
• 238000004458 analytical method Methods 0.000 description 23
• 210000002950 fibroblast Anatomy 0.000 description 23
• 238000002955 isolation Methods 0.000 description 22
• XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 22
• 238000000684 flow cytometry Methods 0.000 description 21
• 239000012737 fresh medium Substances 0.000 description 21
• 229960002885 histidine Drugs 0.000 description 21
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 20
• CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 20
• QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 20
• QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 20
• CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 20
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 20
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 20
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 20
• LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 20
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 20
• 229960003767 alanine Drugs 0.000 description 20
• 229960005261 aspartic acid Drugs 0.000 description 20
• 239000007640 basal medium Substances 0.000 description 20
• 229940098773 bovine serum albumin Drugs 0.000 description 20
• 229960003067 cystine Drugs 0.000 description 20
• 229960000310 isoleucine Drugs 0.000 description 20
• 239000002245 particle Substances 0.000 description 20
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 20
• 210000001113 umbilicus Anatomy 0.000 description 20
• 108010003272 Hyaluronate lyase Proteins 0.000 description 19
• 102000001974 Hyaluronidases Human genes 0.000 description 19
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 19
• 229930064664 L-arginine Natural products 0.000 description 19
• 235000014852 L-arginine Nutrition 0.000 description 19
• 239000004158 L-cystine Substances 0.000 description 19
• 235000019393 L-cystine Nutrition 0.000 description 19
• 229930182844 L-isoleucine Natural products 0.000 description 19
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
• BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 19
• 238000003306 harvesting Methods 0.000 description 19
• 229960002773 hyaluronidase Drugs 0.000 description 19
• 229910052760 oxygen Inorganic materials 0.000 description 19
• 102000004169 proteins and genes Human genes 0.000 description 19
• 235000015921 sodium selenite Nutrition 0.000 description 19
• 239000011781 sodium selenite Substances 0.000 description 19
• 229960001471 sodium selenite Drugs 0.000 description 19
• 102000008186 Collagen Human genes 0.000 description 18
• 108010035532 Collagen Proteins 0.000 description 18
• 108010017842 Telomerase Proteins 0.000 description 18
• 229920001436 collagen Polymers 0.000 description 18
• 229940061607 dibasic sodium phosphate Drugs 0.000 description 18
• 239000011521 glass Substances 0.000 description 18
• 229960002989 glutamic acid Drugs 0.000 description 18
• 238000011534 incubation Methods 0.000 description 18
• 235000018102 proteins Nutrition 0.000 description 18
• OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 17
• 239000011324 bead Substances 0.000 description 17
• FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 17
• 235000000639 cyanocobalamin Nutrition 0.000 description 17
• 239000011666 cyanocobalamin Substances 0.000 description 17
• 229960002104 cyanocobalamin Drugs 0.000 description 17
• 229960000304 folic acid Drugs 0.000 description 17
• 235000019152 folic acid Nutrition 0.000 description 17
• 239000011724 folic acid Substances 0.000 description 17
• 230000008569 process Effects 0.000 description 17
• 229940011671 vitamin b6 Drugs 0.000 description 17
• 102000004890 Interleukin-8 Human genes 0.000 description 16
• 108090001007 Interleukin-8 Proteins 0.000 description 16
• JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 16
• 230000001464 adherent effect Effects 0.000 description 16
• 230000029087 digestion Effects 0.000 description 16
• 229940045641 monobasic sodium phosphate Drugs 0.000 description 16
• 210000002826 placenta Anatomy 0.000 description 16
• 235000008160 pyridoxine Nutrition 0.000 description 16
• 239000011677 pyridoxine Substances 0.000 description 16
• AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 16
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 16
• 229960003495 thiamine Drugs 0.000 description 16
• 235000019157 thiamine Nutrition 0.000 description 16
• KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 16
• 239000011721 thiamine Substances 0.000 description 16
• 229960004441 tyrosine Drugs 0.000 description 16
• 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 15
• 235000019743 Choline chloride Nutrition 0.000 description 15
• AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 15
• DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 15
• SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 15
• 229960003178 choline chloride Drugs 0.000 description 15
• 239000000306 component Substances 0.000 description 15
• 229940096397 interleukin-8 Drugs 0.000 description 15
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 15
• 210000002901 mesenchymal stem cell Anatomy 0.000 description 15
• 229960003966 nicotinamide Drugs 0.000 description 15
• 235000005152 nicotinamide Nutrition 0.000 description 15
• 239000011570 nicotinamide Substances 0.000 description 15
• 229960005190 phenylalanine Drugs 0.000 description 15
• 239000001103 potassium chloride Substances 0.000 description 15
• 235000011164 potassium chloride Nutrition 0.000 description 15
• 229960003581 pyridoxal Drugs 0.000 description 15
• 235000008164 pyridoxal Nutrition 0.000 description 15
• 239000011674 pyridoxal Substances 0.000 description 15
• 229960002477 riboflavin Drugs 0.000 description 15
• 235000019192 riboflavin Nutrition 0.000 description 15
• 239000002151 riboflavin Substances 0.000 description 15
• 239000000523 sample Substances 0.000 description 15
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 14
• 108010010803 Gelatin Proteins 0.000 description 14
• 239000004201 L-cysteine Substances 0.000 description 14
• 235000013878 L-cysteine Nutrition 0.000 description 14
• 239000005700 Putrescine Substances 0.000 description 14
• 239000010949 copper Substances 0.000 description 14
• 229910052802 copper Inorganic materials 0.000 description 14
• 229940068840 d-biotin Drugs 0.000 description 14
• 229920000159 gelatin Polymers 0.000 description 14
• 239000008273 gelatin Substances 0.000 description 14
• 235000019322 gelatine Nutrition 0.000 description 14
• 235000011852 gelatine desserts Nutrition 0.000 description 14
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 14
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 13
• 239000004472 Lysine Substances 0.000 description 13
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 13
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 13
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 13
• 230000010261 cell growth Effects 0.000 description 13
• 102100032912 CD44 antigen Human genes 0.000 description 12
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 12
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 12
• 235000019766 L-Lysine Nutrition 0.000 description 12
• 108090000028 Neprilysin Proteins 0.000 description 12
• 102000003729 Neprilysin Human genes 0.000 description 12
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 12
• 108090000631 Trypsin Proteins 0.000 description 12
• 102000004142 Trypsin Human genes 0.000 description 12
• 230000000694 effects Effects 0.000 description 12
• 238000009472 formulation Methods 0.000 description 12
• 229940076153 heptahydrate zinc sulfate Drugs 0.000 description 12
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 12
• 235000019341 magnesium sulphate Nutrition 0.000 description 12
• 210000003205 muscle Anatomy 0.000 description 12
• 230000000737 periodic effect Effects 0.000 description 12
• 229920001993 poloxamer 188 Polymers 0.000 description 12
• 238000010186 staining Methods 0.000 description 12
• 239000012588 trypsin Substances 0.000 description 12
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 11
• 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 11
• FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 description 11
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 11
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 11
• 229930182555 Penicillin Natural products 0.000 description 11
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 11
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 11
• 102100035071 Vimentin Human genes 0.000 description 11
• 108010065472 Vimentin Proteins 0.000 description 11
• 108020004707 nucleic acids Proteins 0.000 description 11
• 102000039446 nucleic acids Human genes 0.000 description 11
• 150000007523 nucleic acids Chemical class 0.000 description 11
• 229940049954 penicillin Drugs 0.000 description 11
• 229960004799 tryptophan Drugs 0.000 description 11
• 210000005048 vimentin Anatomy 0.000 description 11
• 108010014423 Chemokine CXCL6 Proteins 0.000 description 10
• 239000001110 calcium chloride Substances 0.000 description 10
• 229910001628 calcium chloride Inorganic materials 0.000 description 10
• 235000011148 calcium chloride Nutrition 0.000 description 10
• 238000004113 cell culture Methods 0.000 description 10
• 239000006285 cell suspension Substances 0.000 description 10
• 229940126864 fibroblast growth factor Drugs 0.000 description 10
• VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 description 10
• 239000008188 pellet Substances 0.000 description 10
• 239000011780 sodium chloride Substances 0.000 description 10
• 229960005322 streptomycin Drugs 0.000 description 10
• 229960004295 valine Drugs 0.000 description 10
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 9
• 210000002798 bone marrow cell Anatomy 0.000 description 9
• 239000002299 complementary DNA Substances 0.000 description 9
• 229960003136 leucine Drugs 0.000 description 9
• 239000000463 material Substances 0.000 description 9
• 229960004452 methionine Drugs 0.000 description 9
• 238000002360 preparation method Methods 0.000 description 9
• 230000003068 static effect Effects 0.000 description 9
• 239000011573 trace mineral Substances 0.000 description 9
• 235000013619 trace mineral Nutrition 0.000 description 9
• 238000011282 treatment Methods 0.000 description 9
• 102100022464 5'-nucleotidase Human genes 0.000 description 8
• 102000007469 Actins Human genes 0.000 description 8
• 108010085238 Actins Proteins 0.000 description 8
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 8
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 8
• 238000003556 assay Methods 0.000 description 8
• 238000005119 centrifugation Methods 0.000 description 8
• 230000008774 maternal effect Effects 0.000 description 8
• 108020004999 messenger RNA Proteins 0.000 description 8
• 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 8
• 229940054269 sodium pyruvate Drugs 0.000 description 8
• WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 8
• QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 7
• 102100036912 Desmin Human genes 0.000 description 7
• 108010044052 Desmin Proteins 0.000 description 7
• 102100037362 Fibronectin Human genes 0.000 description 7
• 239000004471 Glycine Substances 0.000 description 7
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 7
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 7
• 102000004889 Interleukin-6 Human genes 0.000 description 7
• 108090001005 Interleukin-6 Proteins 0.000 description 7
• 239000004395 L-leucine Substances 0.000 description 7
• 235000019454 L-leucine Nutrition 0.000 description 7
• 229930182821 L-proline Natural products 0.000 description 7
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 7
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 7
• 241000508269 Psidium Species 0.000 description 7
• 239000004473 Threonine Substances 0.000 description 7
• 229930003270 Vitamin B Natural products 0.000 description 7
• 239000007864 aqueous solution Substances 0.000 description 7
• 239000011248 coating agent Substances 0.000 description 7
• 210000005045 desmin Anatomy 0.000 description 7
• 238000011081 inoculation Methods 0.000 description 7
• 229940100601 interleukin-6 Drugs 0.000 description 7
• 238000003752 polymerase chain reaction Methods 0.000 description 7
• 229960002429 proline Drugs 0.000 description 7
• 229960001153 serine Drugs 0.000 description 7
• IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 7
• 239000007787 solid Substances 0.000 description 7
• 239000000758 substrate Substances 0.000 description 7
• 229960002898 threonine Drugs 0.000 description 7
• 238000012546 transfer Methods 0.000 description 7
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 7
• 230000001228 trophic effect Effects 0.000 description 7
• 235000019156 vitamin B Nutrition 0.000 description 7
• 239000011720 vitamin B Substances 0.000 description 7
• 108010047303 von Willebrand Factor Proteins 0.000 description 7
• SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 description 6
• PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 6
• APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 6
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 6
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 6
• 102100036845 C-C motif chemokine 22 Human genes 0.000 description 6
• 108010083701 Chemokine CCL22 Proteins 0.000 description 6
• 229920002307 Dextran Polymers 0.000 description 6
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
• 108010067306 Fibronectins Proteins 0.000 description 6
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 6
• 108010075704 HLA-A Antigens Proteins 0.000 description 6
• 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 6
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 6
• 101000763314 Homo sapiens Thrombomodulin Proteins 0.000 description 6
• 102100033421 Keratin, type I cytoskeletal 18 Human genes 0.000 description 6
• 108010066327 Keratin-18 Proteins 0.000 description 6
• FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 6
• 229930195722 L-methionine Natural products 0.000 description 6
• 102000007547 Laminin Human genes 0.000 description 6
• 108010085895 Laminin Proteins 0.000 description 6
• 102000035092 Neutral proteases Human genes 0.000 description 6
• 108091005507 Neutral proteases Proteins 0.000 description 6
• 102100033762 Proheparin-binding EGF-like growth factor Human genes 0.000 description 6
• 102100022647 Reticulon-1 Human genes 0.000 description 6
• 101710122684 Reticulon-1 Proteins 0.000 description 6
• 102100026966 Thrombomodulin Human genes 0.000 description 6
• 238000013019 agitation Methods 0.000 description 6
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 6
• 229960003942 amphotericin b Drugs 0.000 description 6
• 239000012298 atmosphere Substances 0.000 description 6
• 210000004204 blood vessel Anatomy 0.000 description 6
• 210000001185 bone marrow Anatomy 0.000 description 6
• 239000000872 buffer Substances 0.000 description 6
• 239000002458 cell surface marker Substances 0.000 description 6
• 238000002659 cell therapy Methods 0.000 description 6
• 238000012512 characterization method Methods 0.000 description 6
• 210000000349 chromosome Anatomy 0.000 description 6
• 238000000576 coating method Methods 0.000 description 6
• 229960000673 dextrose monohydrate Drugs 0.000 description 6
• 230000004069 differentiation Effects 0.000 description 6
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 6
• 238000000338 in vitro Methods 0.000 description 6
• 239000003446 ligand Substances 0.000 description 6
• 239000003550 marker Substances 0.000 description 6
• 230000005298 paramagnetic effect Effects 0.000 description 6
• 239000004033 plastic Substances 0.000 description 6
• 229920003023 plastic Polymers 0.000 description 6
• 239000011148 porous material Substances 0.000 description 6
• 238000000926 separation method Methods 0.000 description 6
• 239000011734 sodium Substances 0.000 description 6
• 239000003381 stabilizer Substances 0.000 description 6
• 238000004114 suspension culture Methods 0.000 description 6
• 102100036537 von Willebrand factor Human genes 0.000 description 6
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
• 102100034608 Angiopoietin-2 Human genes 0.000 description 5
• 102100023698 C-C motif chemokine 17 Human genes 0.000 description 5
• 241000283707 Capra Species 0.000 description 5
• 108010082169 Chemokine CCL17 Proteins 0.000 description 5
• 238000002965 ELISA Methods 0.000 description 5
• 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 5
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 5
• 108010052014 Liberase Proteins 0.000 description 5
• 108010041111 Thrombopoietin Proteins 0.000 description 5
• 102000036693 Thrombopoietin Human genes 0.000 description 5
• 102000011117 Transforming Growth Factor beta2 Human genes 0.000 description 5
• 101800000304 Transforming growth factor beta-2 Proteins 0.000 description 5
• 239000002253 acid Substances 0.000 description 5
• 150000001412 amines Chemical class 0.000 description 5
• 230000003399 chemotactic effect Effects 0.000 description 5
• 238000009826 distribution Methods 0.000 description 5
• 230000002255 enzymatic effect Effects 0.000 description 5
• 238000002474 experimental method Methods 0.000 description 5
• 210000004700 fetal blood Anatomy 0.000 description 5
• 239000007789 gas Substances 0.000 description 5
• 229960002449 glycine Drugs 0.000 description 5
• 210000003714 granulocyte Anatomy 0.000 description 5
• 210000005260 human cell Anatomy 0.000 description 5
• 210000004940 nucleus Anatomy 0.000 description 5
• 230000035755 proliferation Effects 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 230000028327 secretion Effects 0.000 description 5
• 238000010257 thawing Methods 0.000 description 5
• 230000035899 viability Effects 0.000 description 5
• 150000003722 vitamin derivatives Chemical class 0.000 description 5
• 108010048036 Angiopoietin-2 Proteins 0.000 description 4
• 108090000145 Bacillolysin Proteins 0.000 description 4
• 108010055166 Chemokine CCL5 Proteins 0.000 description 4
• 102000009410 Chemokine receptor Human genes 0.000 description 4
• 108050000299 Chemokine receptor Proteins 0.000 description 4
• 102000050083 Class E Scavenger Receptors Human genes 0.000 description 4
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 4
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 4
• 101000871708 Homo sapiens Proheparin-binding EGF-like growth factor Proteins 0.000 description 4
• 101000931422 Photobacterium phosphoreum Methenyltetrahydrofolate cyclohydrolase Proteins 0.000 description 4
• 239000004365 Protease Substances 0.000 description 4
• 101000752546 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Transaminated amino acid decarboxylase Proteins 0.000 description 4
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
• 102100021947 Survival motor neuron protein Human genes 0.000 description 4
• 108010031318 Vitronectin Proteins 0.000 description 4
• 102100035140 Vitronectin Human genes 0.000 description 4
• 238000003491 array Methods 0.000 description 4
• 239000011575 calcium Substances 0.000 description 4
• 239000000969 carrier Substances 0.000 description 4
• 238000011072 cell harvest Methods 0.000 description 4
• 230000006378 damage Effects 0.000 description 4
• 230000002500 effect on skin Effects 0.000 description 4
• 239000006481 glucose medium Substances 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 239000012139 lysis buffer Substances 0.000 description 4
• 239000003068 molecular probe Substances 0.000 description 4
• 238000002966 oligonucleotide array Methods 0.000 description 4
• 108010071584 oxidized low density lipoprotein Proteins 0.000 description 4
• 239000000047 product Substances 0.000 description 4
• 238000003753 real-time PCR Methods 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 108091005418 scavenger receptor class E Proteins 0.000 description 4
• 239000000725 suspension Substances 0.000 description 4
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 4
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
• PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 3
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 3
• 108700012434 CCL3 Proteins 0.000 description 3
• 102000000013 Chemokine CCL3 Human genes 0.000 description 3
• 102000019034 Chemokines Human genes 0.000 description 3
• 108010012236 Chemokines Proteins 0.000 description 3
• ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
• 208000034423 Delivery Diseases 0.000 description 3
• 102000016911 Deoxyribonucleases Human genes 0.000 description 3
• 108010053770 Deoxyribonucleases Proteins 0.000 description 3
• 238000012286 ELISA Assay Methods 0.000 description 3
• 102100023688 Eotaxin Human genes 0.000 description 3
• 101710139422 Eotaxin Proteins 0.000 description 3
• 101800003838 Epidermal growth factor Proteins 0.000 description 3
• 108090000394 Erythropoietin Proteins 0.000 description 3
• 102000003951 Erythropoietin Human genes 0.000 description 3
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 3
• 229930182566 Gentamicin Natural products 0.000 description 3
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
• 101710091439 Major capsid protein 1 Proteins 0.000 description 3
• 102000018697 Membrane Proteins Human genes 0.000 description 3
• 108010052285 Membrane Proteins Proteins 0.000 description 3
• 102000005741 Metalloproteases Human genes 0.000 description 3
• 108010006035 Metalloproteases Proteins 0.000 description 3
• 102000035195 Peptidases Human genes 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 3
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
• 108010000499 Thromboplastin Proteins 0.000 description 3
• 102100030859 Tissue factor Human genes 0.000 description 3
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 3
• 229930003268 Vitamin C Natural products 0.000 description 3
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
• 239000002518 antifoaming agent Substances 0.000 description 3
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000003115 biocidal effect Effects 0.000 description 3
• 229960002685 biotin Drugs 0.000 description 3
• 235000020958 biotin Nutrition 0.000 description 3
• 239000011616 biotin Substances 0.000 description 3
• 210000001772 blood platelet Anatomy 0.000 description 3
• 239000000648 calcium alginate Substances 0.000 description 3
• 235000010410 calcium alginate Nutrition 0.000 description 3
• 229960002681 calcium alginate Drugs 0.000 description 3
• OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 239000003636 conditioned culture medium Substances 0.000 description 3
• 230000002559 cytogenic effect Effects 0.000 description 3
• 229940119679 deoxyribonucleases Drugs 0.000 description 3
• 238000001514 detection method Methods 0.000 description 3
• 238000010790 dilution Methods 0.000 description 3
• 239000012895 dilution Substances 0.000 description 3
• 201000010099 disease Diseases 0.000 description 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
• 230000005611 electricity Effects 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 238000001976 enzyme digestion Methods 0.000 description 3
• 229940116977 epidermal growth factor Drugs 0.000 description 3
• 229940105423 erythropoietin Drugs 0.000 description 3
• 230000001605 fetal effect Effects 0.000 description 3
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
• 239000004088 foaming agent Substances 0.000 description 3
• 210000003953 foreskin Anatomy 0.000 description 3
• 239000012634 fragment Substances 0.000 description 3
• 230000006870 function Effects 0.000 description 3
• 229960002518 gentamicin Drugs 0.000 description 3
• 239000003102 growth factor Substances 0.000 description 3
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 3
• 238000003364 immunohistochemistry Methods 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 239000011777 magnesium Substances 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 230000031864 metaphase Effects 0.000 description 3
• 229930182817 methionine Natural products 0.000 description 3
• 238000000386 microscopy Methods 0.000 description 3
• 230000000510 mucolytic effect Effects 0.000 description 3
• 229910052757 nitrogen Inorganic materials 0.000 description 3
• 229960000988 nystatin Drugs 0.000 description 3
• VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• 239000001301 oxygen Substances 0.000 description 3
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 230000000717 retained effect Effects 0.000 description 3
• 230000009758 senescence Effects 0.000 description 3
• 235000018716 sodium selenate Nutrition 0.000 description 3
• 239000011655 sodium selenate Substances 0.000 description 3
• 229960001881 sodium selenate Drugs 0.000 description 3
• 238000002054 transplantation Methods 0.000 description 3
• 235000019154 vitamin C Nutrition 0.000 description 3
• 239000011718 vitamin C Substances 0.000 description 3
• 229960001134 von willebrand factor Drugs 0.000 description 3
• 229910052725 zinc Inorganic materials 0.000 description 3
• 239000011701 zinc Substances 0.000 description 3
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
• FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
• 102000009027 Albumins Human genes 0.000 description 2
• 108010088751 Albumins Proteins 0.000 description 2
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 102000001326 Chemokine CCL4 Human genes 0.000 description 2
• 108010055165 Chemokine CCL4 Proteins 0.000 description 2
• 108010014419 Chemokine CXCL1 Proteins 0.000 description 2
• 102000016950 Chemokine CXCL1 Human genes 0.000 description 2
• 108010008951 Chemokine CXCL12 Proteins 0.000 description 2
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
• 102000016942 Elastin Human genes 0.000 description 2
• 108010014258 Elastin Proteins 0.000 description 2
• 241000283074 Equus asinus Species 0.000 description 2
• 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 2
• 101000924488 Homo sapiens Atrial natriuretic peptide receptor 3 Proteins 0.000 description 2
• 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 2
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 2
• 101000608935 Homo sapiens Leukosialin Proteins 0.000 description 2
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 2
• 150000008575 L-amino acids Chemical class 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• 102100039564 Leukosialin Human genes 0.000 description 2
• 102000002452 NPR3 Human genes 0.000 description 2
• 239000004677 Nylon Substances 0.000 description 2
• BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
• 239000004793 Polystyrene Substances 0.000 description 2
• 108010026552 Proteome Proteins 0.000 description 2
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 2
• 102000007000 Tenascin Human genes 0.000 description 2
• 108010008125 Tenascin Proteins 0.000 description 2
• 206010043276 Teratoma Diseases 0.000 description 2
• 108090001109 Thermolysin Proteins 0.000 description 2
• 208000007536 Thrombosis Diseases 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 102100031484 Vesicle-associated membrane protein 5 Human genes 0.000 description 2
• 108091009550 Vesicle-associated membrane protein 5 Proteins 0.000 description 2
• FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
• 229930003779 Vitamin B12 Natural products 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 239000012190 activator Substances 0.000 description 2
• 210000000577 adipose tissue Anatomy 0.000 description 2
• FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
• 210000004381 amniotic fluid Anatomy 0.000 description 2
• 210000004102 animal cell Anatomy 0.000 description 2
• 239000003429 antifungal agent Substances 0.000 description 2
• 239000012867 bioactive agent Substances 0.000 description 2
• 239000012620 biological material Substances 0.000 description 2
• 230000000903 blocking effect Effects 0.000 description 2
• 210000004271 bone marrow stromal cell Anatomy 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 238000005266 casting Methods 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 230000003833 cell viability Effects 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• 229960001231 choline Drugs 0.000 description 2
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 229910000365 copper sulfate Inorganic materials 0.000 description 2
• 229910000336 copper(I) sulfate Inorganic materials 0.000 description 2
• ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
• 210000004748 cultured cell Anatomy 0.000 description 2
• 210000003074 dental pulp Anatomy 0.000 description 2
• 230000001079 digestive effect Effects 0.000 description 2
• 238000010494 dissociation reaction Methods 0.000 description 2
• 230000005593 dissociations Effects 0.000 description 2
• 229920002549 elastin Polymers 0.000 description 2
• 210000002308 embryonic cell Anatomy 0.000 description 2
• 238000005530 etching Methods 0.000 description 2
• 230000007717 exclusion Effects 0.000 description 2
• 210000002744 extracellular matrix Anatomy 0.000 description 2
• 238000000605 extraction Methods 0.000 description 2
• 239000012526 feed medium Substances 0.000 description 2
• 239000012527 feed solution Substances 0.000 description 2
• 238000007667 floating Methods 0.000 description 2
• 210000001654 germ layer Anatomy 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• 108010046018 leukocyte inhibitory factor Proteins 0.000 description 2
• 210000001349 mammary artery Anatomy 0.000 description 2
• 238000005259 measurement Methods 0.000 description 2
• 238000002493 microarray Methods 0.000 description 2
• 239000011859 microparticle Substances 0.000 description 2
• 239000007758 minimum essential medium Substances 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 210000005087 mononuclear cell Anatomy 0.000 description 2
• 238000000465 moulding Methods 0.000 description 2
• 210000002894 multi-fate stem cell Anatomy 0.000 description 2
• QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 2
• 229920001778 nylon Polymers 0.000 description 2
• 230000036542 oxidative stress Effects 0.000 description 2
• 230000037361 pathway Effects 0.000 description 2
• 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 229920001983 poloxamer Polymers 0.000 description 2
• 108010055896 polyornithine Proteins 0.000 description 2
• 229920002714 polyornithine Polymers 0.000 description 2
• 229920002223 polystyrene Polymers 0.000 description 2
• 235000019419 proteases Nutrition 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 238000003118 sandwich ELISA Methods 0.000 description 2
• 238000013341 scale-up Methods 0.000 description 2
• 230000000405 serological effect Effects 0.000 description 2
• 239000012679 serum free medium Substances 0.000 description 2
• 235000017557 sodium bicarbonate Nutrition 0.000 description 2
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
• 239000012192 staining solution Substances 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 238000003756 stirring Methods 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 239000001384 succinic acid Substances 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 229940072041 transforming growth factor beta 2 Drugs 0.000 description 2
• GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• 235000019155 vitamin A Nutrition 0.000 description 2
• 239000011719 vitamin A Substances 0.000 description 2
• 235000019163 vitamin B12 Nutrition 0.000 description 2
• 239000011715 vitamin B12 Substances 0.000 description 2
• 229940045997 vitamin a Drugs 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
• 229960001763 zinc sulfate Drugs 0.000 description 2
• 229910000368 zinc sulfate Inorganic materials 0.000 description 2
• DZUXGQBLFALXCR-UHFFFAOYSA-N (+)-(9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprost-13-en-1-oic acid Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CCCCCCC(O)=O DZUXGQBLFALXCR-UHFFFAOYSA-N 0.000 description 1
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
• UPLLQJUZZIYKHI-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;2-oxobutanedioic acid Chemical compound OC(=O)CC(=O)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O UPLLQJUZZIYKHI-DFWYDOINSA-N 0.000 description 1
• 108020004463 18S ribosomal RNA Proteins 0.000 description 1
• WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
• 101710197633 Actin-1 Proteins 0.000 description 1
• 102100024394 Adipocyte enhancer-binding protein 1 Human genes 0.000 description 1
• 101710105604 Adipocyte enhancer-binding protein 1 Proteins 0.000 description 1
• 102100024090 Aldo-keto reductase family 1 member C3 Human genes 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102100040743 Alpha-crystallin B chain Human genes 0.000 description 1
• 101100457310 Arabidopsis thaliana MIP1A gene Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 102100034605 Atrial natriuretic peptide receptor 3 Human genes 0.000 description 1
• 102100037140 BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like Human genes 0.000 description 1
• 102000004954 Biglycan Human genes 0.000 description 1
• 108090001138 Biglycan Proteins 0.000 description 1
• 241001124532 Bubalus depressicornis Species 0.000 description 1
• 210000003771 C cell Anatomy 0.000 description 1
• 101150116911 CCL3 gene Proteins 0.000 description 1
• 102100037904 CD9 antigen Human genes 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 102100035882 Catalase Human genes 0.000 description 1
• 108010053835 Catalase Proteins 0.000 description 1
• 102000001327 Chemokine CCL5 Human genes 0.000 description 1
• 241000819038 Chichester Species 0.000 description 1
• 108010010786 Cholesterol 25-hydroxylase Proteins 0.000 description 1
• 102100032765 Chordin-like protein 1 Human genes 0.000 description 1
• 101710173231 Chordin-like protein 1 Proteins 0.000 description 1
• 108090000317 Chymotrypsin Proteins 0.000 description 1
• 206010053567 Coagulopathies Diseases 0.000 description 1
• 102100024337 Collagen alpha-1(VIII) chain Human genes 0.000 description 1
• 241001665400 Coracias abyssinicus Species 0.000 description 1
• 108010079362 Core Binding Factor Alpha 3 Subunit Proteins 0.000 description 1
• 102100026533 Cytochrome P450 1A2 Human genes 0.000 description 1
• 101710088434 Cytochrome c oxidase subunit 7A1, mitochondrial Proteins 0.000 description 1
• 102100025629 Cytochrome c oxidase subunit 7A1, mitochondrial Human genes 0.000 description 1
• 102100038493 Cytokine receptor-like factor 1 Human genes 0.000 description 1
• 101710194728 Cytokine receptor-like factor 1 Proteins 0.000 description 1
• 108020004414 DNA Proteins 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 102100032883 DNA-binding protein SATB2 Human genes 0.000 description 1
• 238000008789 Direct Bilirubin Methods 0.000 description 1
• 102100028556 Disheveled-associated activator of morphogenesis 2 Human genes 0.000 description 1
• 101710093421 Disheveled-associated activator of morphogenesis 2 Proteins 0.000 description 1
• 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
• 239000012983 Dulbecco’s minimal essential medium Substances 0.000 description 1
• 102000018386 EGF Family of Proteins Human genes 0.000 description 1
• 108010066486 EGF Family of Proteins Proteins 0.000 description 1
• 102100031814 EGF-containing fibulin-like extracellular matrix protein 1 Human genes 0.000 description 1
• 101710176517 EGF-containing fibulin-like extracellular matrix protein 1 Proteins 0.000 description 1
• 102100021717 Early growth response protein 3 Human genes 0.000 description 1
• 102100033167 Elastin Human genes 0.000 description 1
• 102100031780 Endonuclease Human genes 0.000 description 1
• 108010055191 EphA3 Receptor Proteins 0.000 description 1
• 102100030324 Ephrin type-A receptor 3 Human genes 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 102100028072 Fibroblast growth factor 4 Human genes 0.000 description 1
• 108090000381 Fibroblast growth factor 4 Proteins 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
• 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
• 102100039676 Frizzled-7 Human genes 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
• 108010024164 HLA-G Antigens Proteins 0.000 description 1
• 241000193159 Hathewaya histolytica Species 0.000 description 1
• 102100039165 Heat shock protein beta-1 Human genes 0.000 description 1
• 101710100504 Heat shock protein beta-1 Proteins 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 102000052396 Hephaestin Human genes 0.000 description 1
• 108700038053 Hephaestin Proteins 0.000 description 1
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
• 101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 description 1
• 102100022373 Homeobox protein DLX-5 Human genes 0.000 description 1
• 102100037102 Homeobox protein MOX-2 Human genes 0.000 description 1
• 102100029279 Homeobox protein SIX1 Human genes 0.000 description 1
• 102100027332 Homeobox protein SIX2 Human genes 0.000 description 1
• 101000891982 Homo sapiens Alpha-crystallin B chain Proteins 0.000 description 1
• 101000924533 Homo sapiens Angiopoietin-2 Proteins 0.000 description 1
• 101000740545 Homo sapiens BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like Proteins 0.000 description 1
• 101000947177 Homo sapiens C-X-C motif chemokine 6 Proteins 0.000 description 1
• 101100220044 Homo sapiens CD34 gene Proteins 0.000 description 1
• 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 1
• 101000909492 Homo sapiens Collagen alpha-1(VIII) chain Proteins 0.000 description 1
• 101000655236 Homo sapiens DNA-binding protein SATB2 Proteins 0.000 description 1
• 101000896450 Homo sapiens Early growth response protein 3 Proteins 0.000 description 1
• 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
• 101000885797 Homo sapiens Frizzled-7 Proteins 0.000 description 1
• 101001066129 Homo sapiens Glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
• 101000901627 Homo sapiens Homeobox protein DLX-5 Proteins 0.000 description 1
• 101000955037 Homo sapiens Homeobox protein MOX-2 Proteins 0.000 description 1
• 101000634171 Homo sapiens Homeobox protein SIX1 Proteins 0.000 description 1
• 101000651912 Homo sapiens Homeobox protein SIX2 Proteins 0.000 description 1
• 101001044940 Homo sapiens Insulin-like growth factor-binding protein 2 Proteins 0.000 description 1
• 101001015037 Homo sapiens Integrin beta-7 Proteins 0.000 description 1
• 101000997670 Homo sapiens Integrin beta-8 Proteins 0.000 description 1
• 101001026236 Homo sapiens Intermediate conductance calcium-activated potassium channel protein 4 Proteins 0.000 description 1
• 101000602237 Homo sapiens Neuroblastoma suppressor of tumorigenicity 1 Proteins 0.000 description 1
• 101000904196 Homo sapiens Pancreatic secretory granule membrane major glycoprotein GP2 Proteins 0.000 description 1
• 101000612134 Homo sapiens Procollagen C-endopeptidase enhancer 1 Proteins 0.000 description 1
• 101000736906 Homo sapiens Protein prune homolog 2 Proteins 0.000 description 1
• 101000890554 Homo sapiens Retinal dehydrogenase 2 Proteins 0.000 description 1
• 101000880310 Homo sapiens SH3 and cysteine-rich domain-containing protein Proteins 0.000 description 1
• 101000703741 Homo sapiens Short stature homeobox protein 2 Proteins 0.000 description 1
• 101000617738 Homo sapiens Survival motor neuron protein Proteins 0.000 description 1
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
• 101000626125 Homo sapiens Tetranectin Proteins 0.000 description 1
• 101000830570 Homo sapiens Tumor necrosis factor alpha-induced protein 3 Proteins 0.000 description 1
• 101000964749 Homo sapiens Zinc finger protein 710 Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
• 102100034980 ICOS ligand Human genes 0.000 description 1
• 108091058560 IL8 Proteins 0.000 description 1
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
• 102100022710 Insulin-like growth factor-binding protein 2 Human genes 0.000 description 1
• 102100033016 Integrin beta-7 Human genes 0.000 description 1
• 102100033336 Integrin beta-8 Human genes 0.000 description 1
• 102000003815 Interleukin-11 Human genes 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 102100037441 Intermediate conductance calcium-activated potassium channel protein 4 Human genes 0.000 description 1
• 102100023529 Iroquois-class homeodomain protein IRX-5 Human genes 0.000 description 1
• 101710136127 Iroquois-class homeodomain protein IRX-5 Proteins 0.000 description 1
• 239000007760 Iscove's Modified Dulbecco's Medium Substances 0.000 description 1
• PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
• 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
• 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 1
• 108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 1
• 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 1
• 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
• 101150066297 NPR3 gene Proteins 0.000 description 1
• 102100037142 Neuroblastoma suppressor of tumorigenicity 1 Human genes 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 102000016610 Oxidized LDL Receptors Human genes 0.000 description 1
• 108010028191 Oxidized LDL Receptors Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 102100024019 Pancreatic secretory granule membrane major glycoprotein GP2 Human genes 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 229930040373 Paraformaldehyde Natural products 0.000 description 1
• 102000003982 Parathyroid hormone Human genes 0.000 description 1
• 108090000445 Parathyroid hormone Proteins 0.000 description 1
• 102100041026 Procollagen C-endopeptidase enhancer 1 Human genes 0.000 description 1
• 102100038931 Proenkephalin-A Human genes 0.000 description 1
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 1
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 1
• 108010065942 Prostaglandin-F synthase Proteins 0.000 description 1
• 102100036040 Protein prune homolog 2 Human genes 0.000 description 1
• HNGPZFLHRXCYGZ-VIFPVBQESA-N Pyridosine Chemical compound CC1=CC(=O)C(O)=CN1CCCC[C@H](N)C(O)=O HNGPZFLHRXCYGZ-VIFPVBQESA-N 0.000 description 1
• LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
• 238000002123 RNA extraction Methods 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 102100040070 Retinal dehydrogenase 2 Human genes 0.000 description 1
• 102100025369 Runt-related transcription factor 3 Human genes 0.000 description 1
• 102100037646 SH3 and cysteine-rich domain-containing protein Human genes 0.000 description 1
• 102000012479 Serine Proteases Human genes 0.000 description 1
• 108010022999 Serine Proteases Proteins 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 102100031976 Short stature homeobox protein 2 Human genes 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 229920002385 Sodium hyaluronate Polymers 0.000 description 1
• 102000013275 Somatomedins Human genes 0.000 description 1
• 208000002220 Supravalvular aortic stenosis Diseases 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
• 241000120020 Tela Species 0.000 description 1
• 102100032938 Telomerase reverse transcriptase Human genes 0.000 description 1
• 102100024554 Tetranectin Human genes 0.000 description 1
• 102000011923 Thyrotropin Human genes 0.000 description 1
• 108010061174 Thyrotropin Proteins 0.000 description 1
• 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
• 102000003929 Transaminases Human genes 0.000 description 1
• 108090000340 Transaminases Proteins 0.000 description 1
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102100024596 Tumor necrosis factor alpha-induced protein 3 Human genes 0.000 description 1
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
• 229930003427 Vitamin E Natural products 0.000 description 1
• 108010006886 Vitrogen Proteins 0.000 description 1
• 206010049644 Williams syndrome Diseases 0.000 description 1
• 201000001305 Williams-Beuren syndrome Diseases 0.000 description 1
• 210000002593 Y chromosome Anatomy 0.000 description 1
• 102100040663 Zinc finger protein 710 Human genes 0.000 description 1
• PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 229960004308 acetylcysteine Drugs 0.000 description 1
• 210000004504 adult stem cell Anatomy 0.000 description 1
• 239000012574 advanced DMEM Substances 0.000 description 1
• 238000011129 allogeneic cell therapy Methods 0.000 description 1
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
• 235000019270 ammonium chloride Nutrition 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 239000002870 angiogenesis inducing agent Substances 0.000 description 1
• 230000002491 angiogenic effect Effects 0.000 description 1
• 230000001857 anti-mycotic effect Effects 0.000 description 1
• 239000003146 anticoagulant agent Substances 0.000 description 1
• 229940127219 anticoagulant drug Drugs 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 239000002543 antimycotic Substances 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 235000009697 arginine Nutrition 0.000 description 1
• 210000001367 artery Anatomy 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 210000002459 blastocyst Anatomy 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 239000012888 bovine serum Substances 0.000 description 1
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 239000005018 casein Substances 0.000 description 1
• BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
• 235000021240 caseins Nutrition 0.000 description 1
• 229940105657 catalase Drugs 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 238000012832 cell culture technique Methods 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 210000003855 cell nucleus Anatomy 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 239000000919 ceramic Substances 0.000 description 1
• 210000000038 chest Anatomy 0.000 description 1
• 229960002376 chymotrypsin Drugs 0.000 description 1
• 230000035602 clotting Effects 0.000 description 1
• 229940072738 combination collagenase Drugs 0.000 description 1
• 230000001143 conditioned effect Effects 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 230000001186 cumulative effect Effects 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• 238000013480 data collection Methods 0.000 description 1
• 239000008367 deionised water Substances 0.000 description 1
• 229910021641 deionized water Inorganic materials 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
• 238000002224 dissection Methods 0.000 description 1
• 238000011143 downstream manufacturing Methods 0.000 description 1
• 210000003981 ectoderm Anatomy 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 201000011025 embryonal testis carcinoma Diseases 0.000 description 1
• 210000001671 embryonic stem cell Anatomy 0.000 description 1
• 210000001900 endoderm Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 230000006862 enzymatic digestion Effects 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 210000000646 extraembryonic cell Anatomy 0.000 description 1
• 210000002219 extraembryonic membrane Anatomy 0.000 description 1
• 210000000604 fetal stem cell Anatomy 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 239000000706 filtrate Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000013020 final formulation Substances 0.000 description 1
• MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
• 229940028334 follicle stimulating hormone Drugs 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
• 239000007792 gaseous phase Substances 0.000 description 1
• 238000003633 gene expression assay Methods 0.000 description 1
• 238000011223 gene expression profiling Methods 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 210000003566 hemangioblast Anatomy 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 102000047486 human GAPDH Human genes 0.000 description 1
• 229920002674 hyaluronan Polymers 0.000 description 1
• 229960003160 hyaluronic acid Drugs 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
• 238000007654 immersion Methods 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 230000002055 immunohistochemical effect Effects 0.000 description 1
• 239000003547 immunosorbent Substances 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 229960000367 inositol Drugs 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 229940074383 interleukin-11 Drugs 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 238000011031 large-scale manufacturing process Methods 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 230000000503 lectinlike effect Effects 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 235000018977 lysine Nutrition 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 210000001161 mammalian embryo Anatomy 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 238000011177 media preparation Methods 0.000 description 1
• 239000012533 medium component Substances 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 210000003716 mesoderm Anatomy 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 238000007799 mixed lymphocyte reaction assay Methods 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 150000004682 monohydrates Chemical class 0.000 description 1
• 230000000921 morphogenic effect Effects 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 210000000663 muscle cell Anatomy 0.000 description 1
• 210000003098 myoblast Anatomy 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 230000000324 neuroprotective effect Effects 0.000 description 1
• 230000000508 neurotrophic effect Effects 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 229920002866 paraformaldehyde Polymers 0.000 description 1
• 239000000199 parathyroid hormone Substances 0.000 description 1
• 229960001319 parathyroid hormone Drugs 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 150000004686 pentahydrates Chemical class 0.000 description 1
• 108010011903 peptide receptors Proteins 0.000 description 1
• 102000014187 peptide receptors Human genes 0.000 description 1
• 210000003668 pericyte Anatomy 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• HTYIXCKSEQQCJO-UHFFFAOYSA-N phenaglycodol Chemical compound CC(C)(O)C(C)(O)C1=CC=C(Cl)C=C1 HTYIXCKSEQQCJO-UHFFFAOYSA-N 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 230000003169 placental effect Effects 0.000 description 1
• 210000005059 placental tissue Anatomy 0.000 description 1
• 210000001778 pluripotent stem cell Anatomy 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 235000015497 potassium bicarbonate Nutrition 0.000 description 1
• 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
• 239000011736 potassium bicarbonate Substances 0.000 description 1
• TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
• 230000035935 pregnancy Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 108010041071 proenkephalin Proteins 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 238000003498 protein array Methods 0.000 description 1
• FCHXJFJNDJXENQ-UHFFFAOYSA-N pyridoxal hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(C=O)=C1O FCHXJFJNDJXENQ-UHFFFAOYSA-N 0.000 description 1
• WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
• 229940076788 pyruvate Drugs 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 239000012266 salt solution Substances 0.000 description 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
• 239000004017 serum-free culture medium Substances 0.000 description 1
• 210000002363 skeletal muscle cell Anatomy 0.000 description 1
• 210000001626 skin fibroblast Anatomy 0.000 description 1
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
• 229940010747 sodium hyaluronate Drugs 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
• 108010048090 soybean lectin Proteins 0.000 description 1
• 230000000920 spermatogeneic effect Effects 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 229960002385 streptomycin sulfate Drugs 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 238000013337 sub-cultivation Methods 0.000 description 1
• 230000001502 supplementing effect Effects 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 210000002504 synaptic vesicle Anatomy 0.000 description 1
• 108010057210 telomerase RNA Proteins 0.000 description 1
• 102000055501 telomere Human genes 0.000 description 1
• 108091035539 telomere Proteins 0.000 description 1
• 210000003411 telomere Anatomy 0.000 description 1
• 229920000208 temperature-responsive polymer Polymers 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 206010062123 testicular embryonal carcinoma Diseases 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 238000012384 transportation and delivery Methods 0.000 description 1
• GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
• 238000001665 trituration Methods 0.000 description 1
• 102000003390 tumor necrosis factor Human genes 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 210000003556 vascular endothelial cell Anatomy 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 238000011219 vial thaw Methods 0.000 description 1
• 235000019165 vitamin E Nutrition 0.000 description 1
• 229940046009 vitamin E Drugs 0.000 description 1
• 239000011709 vitamin E Substances 0.000 description 1
• 239000011534 wash buffer Substances 0.000 description 1
• 229910052727 yttrium Inorganic materials 0.000 description 1